Point72 Asset Management
UTHR icon

Point72 Asset Management’s United Therapeutics UTHR Stock Holding History

Point72 Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.5M Sell
149,303
-36,861
-20% -$18.4M 0.11% 195
2025
Q4 		$90.7M Buy
186,164
+86,380
+87% +$40.2M 0.1% 207
2025
Q3 		$41.8M Buy
+99,784
New +$33.6M 0.07% 306
2024
Q2 		– Sell
-162,700
Closed -$37.4M – 2477
2024
Q1 		$37.4M Buy
+162,700
New +$36.7M 0.09% 268
2023
Q4 		– Sell
-1,037
Closed -$234K – 2865
2023
Q3 		$234K Sell
1,037
-10,863
-91% -$2.5M ﹤0.01% 1729
2023
Q2 		$2.63M Buy
+11,900
New +$2.64M 0.01% 984
2022
Q3 		– Sell
-19,815
Closed -$4.67M – 1753
2022
Q2 		$4.67M Sell
19,815
-177,285
-90% -$36M 0.02% 725
2022
Q1 		$35.4M Sell
197,100
-10,100
-5% -$1.92M 0.14% 199
2021
Q4 		$44.8M Buy
207,200
+300
+0.1% +$58.9K 0.18% 155
2021
Q3 		$38.2M Sell
206,900
-345,500
-63% -$68.1M 0.17% 149
2021
Q2 		$99.1M Buy
+552,400
New +$105M 0.45% 41
2021
Q1 		– Sell
-343,201
Closed -$52.1M – 1188
2020
Q4 		$52.1M Sell
343,201
-97,326
-22% -$12.8M 0.25% 89
2020
Q3 		$44.5M Buy
440,527
+171,218
+64% +$18.8M 0.23% 110
2020
Q2 		$32.6M Sell
269,309
-309,839
-53% -$34.9M 0.21% 134
2020
Q1 		$54.9M Buy
+579,148
New +$55M 0.45% 51
2019
Q4 		– Sell
-640,243
Closed -$51.1M – 1266
2019
Q3 		$51.1M Buy
640,243
+180,803
+39% +$14.6M 0.31% 79
2019
Q2 		$35.9M Buy
+459,440
New +$43M 0.19% 144
2019
Q1 		– Sell
-133,643
Closed -$14.6M – 1245
2018
Q4 		$14.6M Buy
+133,643
New +$15.5M 0.07% 329
2018
Q3 		– Sell
-2,776
Closed -$314K – 1232
2018
Q2 		$314K Sell
2,776
-1,336
-32% -$147K ﹤0.01% 889
2018
Q1 		$462K Sell
4,112
-187,887
-98% -$23.9M ﹤0.01% 859
2017
Q4 		$28.4M Buy
+191,999
New +$24.4M 0.12% 229
2014
Q4 		– Sell
-8,700
Closed -$1.12M – 800
2014
Q3 		$1.12M Buy
+8,700
New +$897K 0.01% 549

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Point72 Asset Management's UTHR Position: Q1 2026 in Review

Point72 Asset Management reduced its United Therapeutics (UTHR) stake by 20% in Q1 2026, selling an estimated $18.4M and leaving 149,303 shares worth $88.5M. The position accounts for 0.11% of the portfolio, ranked #195.

Point72 Asset Management first reported a position in UTHR in Q3 2014 and has held it in 22 quarters since. The position peaked at $99.1M in Q2 2021. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Point72 Asset Management held 149,303 shares of United Therapeutics worth $88.5M as of Q1 2026.
  • Point72 Asset Management sold 36,861 United Therapeutics shares in Q1 2026, an estimated $18.4M.
  • United Therapeutics made up 0.11% of Point72 Asset Management's portfolio in Q1 2026, its #195 holding.
  • Point72 Asset Management first reported a position in United Therapeutics in Q3 2014 and has held it in 22 quarters since.
  • Point72 Asset Management's United Therapeutics position peaked at $99.1M in Q2 2021.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.